Table 3.
Clinical data of children diagnosed with multisystem inflammatory syndrome
| Median age (years) | ICU admissions, n (%) | Deaths, n (%) | Ventilated, n (%) | ECMO, n (%) | Positive SARS-CoV-2 serum serology, n (%) | Positive nasopharyngeal SARS-CoV-2 RT-PCR | |
|---|---|---|---|---|---|---|---|
| Whittaker et al. (UK) (N = 58) [39] | 9 (IQR 5.7–14) | 29 (50) | 1 (2) | 25 (43) | 3 (5) | 40/46 (87) | 15 (26) |
| Feldstein et al. (US) (N = 186) [44] | 8.3 (IQR 3.3–12.5) | 148 (80) | 4 (2) | 37 (20) | 8 (4) | 73 (39) | 58 (31) |
| Toubiana et al. (France) (N = 21) [41] | 7.9 (range 3.7–16.6) | 17 (81) | 0 | 11 (52) | N/A | 19 (90) | 8 (38) |
| Verdoni et al. (Italy) (N = 10) [38] | 7.5 (SD ± 3.5) | N/A | 0 | 0 | 0 | 8 (80) | 2 (20) |
| CDC MMRW (US) (N = 570) [43]a | 8 (range 2 weeks–20) | 364 (64) | 10 (1.8) | 69 (13) | N/A | 418 (73.2) | 302 (53) |
UK United Kingdom, US United states, IQR interquartile range, ICU intensive care unit, ECMO extra-corporal membrane oxygenation, RT-PCR reverse transcription–polymerase chain reaction, N/A not available
aSince this report included all reported cases in the United States, it is reasonable to assume that patients from the cohort by Feldstein et al. were also reported